Questions: Psychostimulant Mechanisms: Cocaine and Methamphetamine

Question 1

A researcher blocks all action potentials in dopaminergic neurons (preventing vesicular release) and then administers cocaine to one subject and methamphetamine to another. What would happen to synaptic dopamine levels?

• A. Neither drug increases synaptic dopamine, since both require vesicular release triggered by action potentials
• B. Cocaine increases synaptic dopamine but methamphetamine does not, since cocaine acts on already-released dopamine while methamphetamine requires normal neuronal firing
• C. Methamphetamine increases synaptic dopamine but cocaine does not, since methamphetamine reverses DAT to release cytoplasmic dopamine independently of vesicular release
• D. Both drugs equally increase synaptic dopamine, since both work by blocking the dopamine transporter

Answer: (C)

Cocaine is a competitive reuptake inhibitor — it prevents clearance of dopamine already in the synapse but does not itself cause release. Without vesicular release (action potentials blocked), cocaine has no dopamine to protect and cannot increase synaptic levels. Methamphetamine is fundamentally different: it enters the presynaptic terminal and reverses DAT, actively pumping cytoplasmic dopamine into the synapse independently of vesicular release or action potentials. This mechanistic difference — blocking vs. reversing the transporter — explains methamphetamine's greater acute potency, longer duration, and higher neurotoxicity.

Question 2

Why does chronic methamphetamine use cause greater long-term damage to dopaminergic terminals than chronic cocaine use at equivalent doses?

• A. Methamphetamine is more potent, causing more acute receptor stimulation in the short term
• B. Cocaine is metabolized faster, so total cumulative dopamine exposure is lower with cocaine
• C. Methamphetamine's reverse DAT transport floods the terminal with cytoplasmic dopamine, and methamphetamine also crosses into mitochondria to inhibit oxidative phosphorylation, generating reactive oxygen species that directly damage terminals
• D. Methamphetamine blocks both DAT and SERT simultaneously, causing greater combined monoamine disruption

Answer: (C)

The combination of massive dopamine flooding (via reverse DAT transport and disruption of VMAT2 vesicular storage) and direct mitochondrial toxicity (methamphetamine is sufficiently lipid-soluble to enter mitochondria and disrupt oxidative phosphorylation) generates reactive oxygen species. This oxidative stress, combined with the cytoplasmic dopamine flood, causes direct damage to dopaminergic axon terminals — especially in the striatum and prefrontal cortex. Cocaine, which only prevents reuptake without reversing the transporter or entering mitochondria, does not produce equivalent terminal damage.

Question 3

Both cocaine and methamphetamine increase synaptic dopamine by the same mechanism: blocking the dopamine transporter (DAT).

• T. True
• F. False

Answer: False

This is the key distinction. Cocaine is a competitive reuptake inhibitor — it occupies DAT's binding site and prevents the transporter from clearing already-released dopamine. Methamphetamine does something more aggressive: it enters the presynaptic neuron and causes reverse transport — DAT runs backwards, actively pumping dopamine from the cytoplasm into the synapse, independent of vesicular release. Methamphetamine also disrupts VMAT2 (vesicular monoamine transporter) and inhibits MAO. These mechanistic differences produce larger and longer-lasting dopamine surges, greater neurotoxicity, and a distinct addiction trajectory.

Question 4

Chronic stimulant use leads to downregulation of D2 dopamine receptors in the nucleus accumbens, contributing to anhedonia and compulsive drug-seeking.

• T. True
• F. False

Answer: True

Persistent overstimulation of postsynaptic D2 receptors by chronically elevated dopamine triggers homeostatic downregulation — cells reduce receptor density to compensate. PET imaging confirms dramatically reduced D2 receptor availability in people with stimulant use disorder, persisting months into abstinence. The resulting hypodopaminergic baseline produces anhedonia: normal rewards (food, social contact, achievement) no longer generate sufficient dopamine signaling to feel pleasurable. The reward system's gain has been permanently turned down, creating the neurobiological substrate for compulsive use.

Question 5

Explain the shift from positive to negative reinforcement in stimulant addiction. What neurobiological change underlies this transition, and why does it make the addiction so difficult to stop?

Model answer: Initially, stimulants produce intense pleasure via massive dopamine elevation in the nucleus accumbens — positive reinforcement (approaching reward). But chronic overstimulation triggers D2 receptor downregulation, establishing a hypodopaminergic baseline. The user now experiences anhedonia during abstinence because the reward system has adapted to drug-elevated dopamine as its new normal. Avoiding this misery — not seeking euphoria — becomes the primary motive: negative reinforcement (escaping aversion). Quitting requires tolerating prolonged anhedonia while D2 receptor density slowly recovers over months. The difficulty is not simply craving pleasure; it is escaping a chronically dysphoric state that only the drug temporarily relieves.

The transition from positive to negative reinforcement marks a qualitative shift in the nature of dependence. Positive reinforcement means the drug competes against other rewards for approach behavior. Negative reinforcement means the drug's absence creates a distinct aversive state (beyond baseline) that the drug alone relieves. This is why addiction is described as compulsive rather than merely habitual: the cost of not using becomes high, not just the benefit of using. D2 downregulation is the neurobiological mechanism that transforms the reward signal.